Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, July 17, 2015

Extrasynaptic NMDA Receptor in Excitotoxicity Function Revisited

How will your doctor use this information to stop the neuronal cascade of death from the excitotoxity cause?
http://nro.sagepub.com/content/21/4/337.abstract?&
  1. Xianju Zhou1
  2. Zhuoyou Chen1
  3. Wenwei Yun1
  4. Jianhua Ren2
  5. Chengwei Li3
  6. Hongbing Wang4
  1. 1Department of Neurology, Changzhou No. 2 People’s Hospital, The Affiliated Hospital of Nanjing Medical University, Changzhou, China
  2. 2Key Laboratory of Translational Neuroscience, Zhoukou Normal University, Zhoukou China
  3. 3College of Life Science and Agronomy, Zhoukou Normal University, Zhoukou China
  4. 4Department of Physiology and Neuroscience Program, Michigan State University, East Lansing, MI, USA
  1. Xianju Zhou, Department of Neurology, Changzhou No.2 People’s Hospital, the affiliated Hospital of Nanjing Medical University, 29 Xinglong Alley, Changzhou, 21003, China. E-mail: hippocampus2007@gmail.com and Hongbing Wang, Department of Physiology and Neuroscience Program, Michigan State University, 567 Wilson Road, Room 2201 BPS Building, East Lansing, MI 48824, USA. Email: wangho@msu.edu

Abstract

It is generally accepted that proper activation of N-methyl-d-aspartate receptors (NMDARs) promotes neuronal survival and supports neuroplasticity, and excessive NMDAR activation leads to pathological outcomes and neurodegeneration. As NMDARs are found at both synaptic and extrasynaptic sites, there is significant interest in determining how NMDARs at different subcellular locations differentially regulate physiological as well as pathological functions. Better understanding of this issue may support the development of therapeutic strategies to attenuate neuronal death or promote normal brain function. Although the current prevailing theory emphasizes the major role of extrasynaptic NMDARs in neurodegeneration, there is growing evidence indicating the involvement of synaptic receptors. It is also evident that physiological functions of the brain also involve extrasynaptic NMDARs. Our recent studies demonstrate that the degree of cell death following neuronal insults depends on the magnitude and duration of synaptic and extrasynaptic receptor co-activation. These new results underscore the importance of revisiting the function of extrasynaptic NMDARs in cell fate. Furthermore, the development of antagonists that preferentially inhibit synaptic or extrasynaptic receptors may better clarify the role of NMDARs in neurodegeneration.

No comments:

Post a Comment